Sanofi and GSK land $2.1 billion deal with U.S. for Covid-19 vaccine development and 100 million doses

The U.S. government’s Operation Warp Speed effort will provide up to $2.1 billion to Sanofi and GlaxoSmithKline to fund development and manufacturing of the companies’ experimental Covid-19 vaccine, the companies announced Friday.